Aktienanalyse zu Kewaunee Scientific Corp (KEQU)KEQUKewaunee Scientific Corp

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. It operates in the Industrials sector (LABORATORY APPARATUS & FURNITURE industry).

Kewaunee Scientific Corp is currently a hold. The stock is priced at $32.92, with a forward P/E of 7.716, indicating potential value, but the recent decline in net income and revenue growth raises concerns. The RSI is at 45.633, suggesting it is neither overbought nor oversold, which means it may not be the best time to buy. The main risk is the 7.5% revenue drop reported in Q4, which could impact future performance.

1 analysts cover KEQU: 1 rate it Buy, 0 Hold and 0 Sell.